Sara Kenkare-Mitra

1.8k citations
5 papers · 1.3k indexed · 1 hit paper · h-index 4
Topics
Alzheimer's disease research and treatments (2 papers)Neuroinflammation and Neurodegeneration Mechanisms (2 papers)Amyotrophic Lateral Sclerosis Research (2 papers)
Partner nations
United StatesJapan

In The Last Decade

Sara Kenkare-Mitra

5 papers receiving 1.3k citations

Hit Papers

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM...200820262014202020084008001.2k

Peers

Sara Kenkare-Mitra
Comparison fields: 5 of 72
  • Oncology 1.0k
  • Radiology, Nuclear Medicine and Imaging 847
  • Molecular Biology 426
  • Pulmonary and Respiratory Medicine 154
  • Immunology 111
Replace Yasuaki Anami with:
Yasuaki Anami United States
Ivan J. Stone United States
Márk Barok Finland
Dhara N. Amin United States
Christel Larbouret France
Dietmar Berndorff Germany
Arris J. Henderson United States
Takashi Nakada Japan
Natalia Sergina United States
Kelly M. Flagella United States
Sara Kenkare-Mitra relative to Yasuaki Anami United States Yasuaki Anami's profile →
Citations per field
00.5×7.8×
Yasuaki Anami · 1×
Citations per year

Countries citing papers authored by Sara Kenkare-Mitra

Since Specialization
Citations

This map shows the geographic impact of Sara Kenkare-Mitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Kenkare-Mitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Kenkare-Mitra more than expected).

Fields of papers citing papers by Sara Kenkare-Mitra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Kenkare-Mitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Kenkare-Mitra. The network helps show where Sara Kenkare-Mitra may publish in the future.

Co-authorship network of co-authors of Sara Kenkare-Mitra

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Kenkare-Mitra. A scholar is included among the top collaborators of Sara Kenkare-Mitra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Kenkare-Mitra. Sara Kenkare-Mitra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 2
2 38
3 6
4 21
5
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugatebreakdown →
1259

About Sara Kenkare-Mitra

Sara Kenkare-Mitra is a scholar working on Neurology, Critical Care and Intensive Care Medicine and Neurology, having authored 5 papers that have together received 1.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and Amyotrophic Lateral Sclerosis Research (2 papers). The work is most often cited by research in Oncology (1.0k citations), Radiology, Nuclear Medicine and Imaging (847 citations) and Immunology and Allergy (56 citations). Sara Kenkare-Mitra has collaborated with scholars based in United States and Japan. Frequent co-authors include Elaine Mai, Hartmut Koeppen, Walter A. Blättler, Gail D. Lewis Phillips, Debra L. Dugger, Wai Lee Wong, Mark X. Sliwkowski, Kathryn L. Parsons, Susan D. Spencer and Ravi Chari. Their work appears in journals such as Cancer Research, International Journal of Molecular Sciences and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026